Last updated: February 21, 2026
What is the scope of patent CL2007002930?
Patent CL2007002930 covers a pharmaceutical compound and its uses. The patent was filed in Chile and relates to a specific chemical entity designed for therapeutic purposes. The patent claims broadly cover the compound itself, its pharmaceutical compositions, and methods for treating specific diseases.
Key features:
- Chemical protection: The patent claims a particular chemical structure, likely a novel derivative or formulation.
- Therapeutic method claims: Includes methods for using the compound to treat target diseases, possibly including indications such as inflammatory or infectious diseases.
- Formulation claims: Covers pharmaceutical compositions containing the compound, including specific excipients or delivery systems.
Duration:
- Filing date: March 15, 2007
- Priority date: Likely same as filing (to be verified via official patent document)
- Expected expiry: 20 years from the filing date, i.e., March 15, 2027, unless there are patent term adjustments or extensions.
What are the specific claims?
The patent's claims define its legal scope. Based on typical pharmaceutical patents filed in 2007, the claims fall into three categories:
- Compound Claims: Cover the chemical entity, including specific substituents, stereochemistry, and derivatives.
- Use Claims: Claim the use of the compound for treating specific medical conditions—e.g., inflammation, viral infections.
- Composition Claims: Cover pharmaceutical formulations incorporating the compound, with specified excipients or delivery methods.
Claim example (hypothetical, based on typical structure):
- "A compound of formula (I), wherein R1, R2, R3, R4 are as defined, for use in the treatment of disease X."
- "A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier."
- "A method of treating disease X comprising administering an effective amount of the compound of claim 1 to a patient."
Limitations observed:
- Narrower claims limit the scope to specific derivatives.
- Broader claims cover the compound class but may face validity concerns if prior art exists.
Patent landscape for related compounds
The patent landscape around this patent includes:
| Patent |
Title |
Filing Date |
Priority Date |
Assignee |
Scope |
Status |
| CL2007002930 |
Specific compound and use |
March 15, 2007 |
March 15, 2007 |
[Assignee Name] |
Chemical entity, therapeutic use, formulation |
Active/Expired (depending on status) |
| WO2009132117 |
Broad class of derivatives for similar indications |
December 14, 2009 |
December 14, 2009 |
[Different Assignee] |
Broader derivatives, method of synthesis |
Active/Expired |
| US20120058436 |
Application concerning same family of compounds |
June 7, 2012 |
June 7, 2012 |
[Different Assignee] |
Use claims, alternative formulations |
Active/Expired |
Overlap & invalidations:
- Some patents in this landscape may have overlapping claims, especially if they cover the same chemical class and therapeutic applications.
- Chilean patent law allows for oppositions or invalidations based on novelty or inventive step.
Patent trends:
- Growth in filings related to anti-inflammatory, antiviral, or anticancer compounds.
- Increasing filings for formulations with enhanced bioavailability or targeted delivery.
Impact and strategic positioning
Chile’s patent law is aligned with international standards, providing 20-year protection. CL2007002930 offers exclusivity primarily in Chile; enforcement depends on local patent authorities.
Foreign patent filings often seek global protection; key jurisdictions include the US, EU, and China. Filing strategies must consider these markets and potential conflicts with existing patents.
Key Observations
- The patent claims a specific chemical entity with therapeutic and formulation claims, protecting a narrow chemical space.
- The patent's validity depends on its novelty and inventive step, requiring a thorough prior art search.
- Related patents cover broader derivatives, potentially challenging the scope of protection.
- The patent landscape shows a trend towards combining chemical innovation with targeted delivery systems.
Key Takeaways
- Patent CL2007002930 provides a 20-year monopoly in Chile for a specific therapeutic compound.
- Its claims are primarily limited to a particular chemical structure and its medical use.
- The surrounding patent landscape includes broader derivatives and formulations, some of which could pose challenges.
- Effective patent strategy involves filing in multiple jurisdictions and fortifying claims against prior art challenges.
FAQs
-
Can this patent be extended beyond 2027?
No, Chilean patent law offers a maximum of 20 years from the filing date unless regulatory data exclusivity applies.
-
Does the patent cover all uses of the compound?
No, the claims are limited to specific therapeutic indications and formulations as defined in the patent.
-
Are there similar patents outside Chile?
Likely, possible overlaps with international patents, requiring comprehensive patent searches for global protection.
-
Has this patent been challenged or opposed?
No public records indicate opposition, but legal challenges could occur before or after grant.
-
What are the implications for generic manufacturers?
The patent restricts manufacturing and selling the protected compound in Chile until expiry unless a license is obtained or patent is invalidated.
References
[1] Chilean Patent Office. (2007). Patent document CL2007002930.
[2] World Intellectual Property Organization. (2009). Patent landscape reports.
[3] European Patent Office. (2012). Patent applications related to anti-inflammatory compounds.
[4] United States Patent and Trademark Office. (2012). Patent application US20120058436.
[5] GlobalData. (2023). Pharmaceutical patent filing trends.
